Vitamin D–Binding Protein and Vitamin D Status of Black Americans and White Americans
Open accessAbstract
BACKGROUND: Low levels of total 25-hydroxyvitamin D are common among black Americans. Vitamin D-binding protein has not been considered in the assessment of vitamin D deficiency. METHODS: In the Healthy Aging in Neighborhoods of Diversity across the Life Span cohort of blacks and whites (2085 participants), we measured levels of total 25-hydroxyvitamin D, vitamin D-binding protein, and parathyroid hormone as well as bone mineral density (BMD). We genotyped study participants for two common polymorphisms in the vitamin D-binding protein gene (rs7041 and rs4588). We estimated levels of bioavailable 25-hydroxyvitamin D in homozygous participants. RESULTS: Mean (±SE) levels of both total 25-hydroxyvitamin D and vitamin D-binding protein were lower in blacks than in whites (total 25-hydroxyvitamin D, 15.6±0.2 ng per milliliter vs. 25.8±0.4 ng per milliliter, P<0.001; vitamin D-binding protein, 168±3 μg per milliliter vs. 337±5 μg per milliliter, P<0.001). Genetic polymorphisms independently appeared to explain 79.4% and 9.9% of the variation in levels of vitamin D-binding protein and total 25-hydroxyvitamin D, respectively. BMD was higher in blacks than in whites (1.05±0.01 g per square centimeter vs. 0.94±0.01 g per square centimeter, P<0.001). Levels of parathyroid hormone increased with decreasing levels of total or bioavailable 25-hydroxyvitamin D (P<0.001 for both relationships), yet within each quintile of parathyroid hormone concentration, blacks had significantly lower levels of total 25-hydroxyvitamin D than whites. Among homozygous participants, blacks and whites had similar levels of bioavailable 25-hydroxyvitamin D overall (2.9±0.1 ng per milliliter and 3.1±0.1 ng per milliliter, respectively; P=0.71) and within quintiles of parathyroid hormone concentration. CONCLUSIONS: Community-dwelling black Americans, as compared with whites, had low levels of total 25-hydroxyvitamin D and vitamin D-binding protein, resulting in similar concentrations of estimated bioavailable 25-hydroxyvitamin D. Racial differences in the prevalence of common genetic polymorphisms provide a likely explanation for this observation. (Funded by the National Institute on Aging and others.).
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Genetic variation in DBP has been deemed the main argument for lower levels of both DBP and 25(OH)D in subjects of African versus European origin, while levels of bioavailable 25(OH)D were similar in both ethnic groups.
“This genetic variation has been deemed the main argument for the observation of lower levels of both DBP and 25(OH)D in subjects of African versus European origin, while levels of bioavailable 25(OH)D were similar in both ethnic groups [80].”
From Role of sex hormone-binding globulin in the free hormone hypothesis and the relevance of free testosterone in androgen physiology (2022) · cites this paper as [80]
The Abstract Results report lower DBP and total 25(OH)D in black Americans than in white Americans, and similar bioavailable 25(OH)D among homozygous participants. The Discussion links lower DBP to a prevalent genetic variant, but says DBP levels only partially explain the racial difference in total 25(OH)D; calling genetic variation the main explanation for both lower levels overstates the finding. Page numbers are not available in our copy. (LLM, conf=0.85)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089 · see citing works
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824 · see citing works
A Melanocortin 1 Receptor Allele Suggests Varying Pigmentation Among Neanderthals
Lalueza-Fox, C., Römpler, H., Caramelli, D., Stäubert, C., Catalano, G., Hughes, D., Rohland, N., Pilli, E., Longo, L., Condemi, S., et al. (2007) · Science · doi:10.1126/science.1147417 · Cited by 292 · see citing works
Flagged first, then by citations
Research works printed but not linked: 39
- [1]Holick MF Vitamin D deficiency N Engl J Med 2007 357 266 81 17634462
- [2]Adams JS Hewison M Update in vitamin D J Clin Endocrinol Metab 2010 95 471 8 20133466 PMC2840860
- [3]Melamed ML Michos ED Post W Astor B 25-Hydroxyvitamin D levels and the risk of mortality in the general population Arch Intern Med 2008 168 1629 37 18695076 PMC2677029
- [4]Wang TJ Pencina MJ Booth SL Vitamin D deficiency and risk of cardiovascular disease Circulation 2008 117 503 11 18180395 PMC2726624
- [5]Thomas MK Lloyd-Jones DM Thadhani RI Hypovitaminosis D in medical inpatients N Engl J Med 1998 338 777 83 9504937
- [6]Cauley JA Lacroix AZ Wu L Serum 25-hydroxyvitamin D concentrations and risk for hip fractures Ann Intern Med 2008 149 242 50 18711154 PMC2743412
- [7]Chapuy MC Arlot ME Duboeuf F Vitamin D3 and calcium to prevent hip fractures in elderly women N Engl J Med 1992 327 1637 42 1331788
- [8]Jackson RD LaCroix AZ Gass M Calcium plus vitamin D supplementation and the risk of fractures N Engl J Med 2006 354 669 83 Erratum, N Engl J Med 2006;354:1102 16481635
- [9]Sanders KM Stuart AL Williamson EJ Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial JAMA 2010 303 1815 22 Erratum, JAMA 2010;303:2357 20460620
- [10]Aloia JF Talwar SA Pollack S Yeh J A randomized controlled trial of vitamin D3 supplementation in African American women Arch Intern Med 2005 165 1618 23 16043680 PMC1464166
- [11]Mitchell DM Henao MP Finkelstein JS Burnett-Bowie SA Prevalence and predictors of vitamin D deficiency in healthy adults Endocr Pract 2012 18 914 23 22982792 PMC3755751
- [12]Gutiérrez OM Farwell WR Kermah D Taylor EN Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the National Health and Nutrition Examination Survey Osteoporos Int 2011 22 1745 53 20848081 PMC3093445
- [13]Ginde AA Liu MC Camargo CA Jr Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004 Arch Intern Med 2009 169 626 32 19307527 PMC3447083
- [14]Hannan MT Litman HJ Araujo AB Serum 25-hydroxyvitamin D and bone mineral density in a racially and ethnically diverse group of men J Clin Endocrinol Metab 2008 93 40 6 17986641 PMC2190744
- [15]Bischoff-Ferrari HA Dietrich T Orav EJ Dawson-Hughes B Positive association between 25-hydroxy vitamin D levels and bone mineral density: a populationbased study of younger and older adults Am J Med 2004 116 634 9 15093761
- [16]Cauley JA Lui LY Ensrud KE Bone mineral density and the risk of incident nonspinal fractures in black and white women JAMA 2005 293 2102 8 15870413
- [17]Kritchevsky SB Tooze JA Neiberg RH 25-Hydroxyvitamin D, parathyroid hormone, and mortality in black and white older adults: the Health ABC study J Clin Endocrinol Metab 2012 97 4156 65 22942386 PMC3485585
- [18]Wright NC Chen L Niu J Defining physiologically “normal” vitamin D in African Americans Osteoporos Int 2012 23 2283 91 22189572 PMC3677509
- [19]Bikle DD Gee E Halloran B Kowalski MA Ryzen E Haddad JG Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein J Clin Endocrinol Metab 1986 63 954 9 3745408
- [20]Safadi FF Thornton P Magiera H Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein J Clin Invest 1999 103 239 51 9916136 PMC407885
- [21]Bikle DD Gee E Free, and not total, 1,25-dihydroxyvitamin D regulates 25-hydroxyvitamin D metabolism by keratinocytes Endocrinology 1989 124 649 54 2463902
- [22]Arnaud J Constans J Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP) Hum Genet 1993 92 183 8 8370586
- [23]Braun A Bichlmaier R Cleve H Molecular analysis of the gene for the human vitamin-D-binding protein (group-specific component): allelic differences of the common genetic GC types Hum Genet 1992 89 401 6 1352271
- [24]Engelman CD Fingerlin TE Langefeld CD Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans J Clin Endocrinol Metab 2008 93 3381 8 18593774 PMC2567851
- [25]Constans J Hazout S Garruto RM Gajdusek DC Spees EK Population distribution of the human vitamin D binding protein: anthropological considerations Am J Phys Anthropol 1985 68 107 22 4061596
- [26]Evans MK Lepkowski JM Powe NR LaVeist T Kuczmarski MF Zonderman AB Healthy Aging in Neighborhoods of Diversity across the Life Span (HANDLS): overcoming barriers to implementing a longitudinal, epidemiologic, urban study of health, race, and socioeconomic status Ethn Dis 2010 20 267 75 20828101 PMC3040595
- [27]Cummings SR Black DM Nevitt MC Bone density at various sites for prediction of hip fractures Lancet 1993 341 72 5 8093403
- [29]Powe CE Ricciardi C Berg AH Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship J Bone Miner Res 2011 26 1609 16 21416506 PMC3351032
- [30]Sai AJ Walters RW Fang X Gallagher JC Relationship between vitamin D, parathyroid hormone, and bone health J Clin Endocrinol Metab 2011 96 E436 46 21159838 PMC3047227
- [31]Rosen CJ Abrams SA Aloia JF IOM committee members respond to Endocrine Society vitamin D guideline J Clin Endocrinol Metab 2012 97 1146 52 22442278 PMC5393439
- [32]Holick MF Binkley NC Bischoff-Ferrari HA Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline J Clin Endocrinol Metab 2011 96 1911 30 Erratum, J Clin Endocrinol Metab 2011;96:3908 21646368
- [34]Mori Y Takeda K Charbonneau M Refetoff S Replacement of Leu227 by Pro in thyroxine-binding globulin (TBG) is associated with complete TBG deficiency in three of eight families with this inherited defect J Clin Endocrinol Metab 1990 70 804 9 2155256
- [35]Wang TJ Zhang F Richards JB Common genetic determinants of vitamin D insufficiency: a genome-wide association study Lancet 2010 376 180 8 20541252 PMC3086761
- [36]Levin GP Robinson-Cohen C de Boer IH Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes JAMA 2012 308 1898 905 23150009 PMC3645444
- [37]Bertrand KA Giovannucci E Liu Y Determinants of plasma 25-hydroxyvitamin D and development of prediction models in three US cohorts Br J Nutr 2012 108 1889 96 22264926 PMC3346859
- [38]Lauridsen AL Vestergaard P Hermann AP Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxyvitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women Calcif Tissue Int 2005 77 15 22 15868280
- [39]Nykjaer A Dragun D Walther D An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3 Cell 1999 96 507 15 10052453
- [40]Aloia JF African Americans, 25-hydroxyvitamin D, and osteoporosis: a paradox Am J Clin Nutr 2008 88 545S 50S 18689399 PMC2777641
- [41]Clemens TL Adams JS Henderson SL Holick MF Increased skin pigment reduces the capacity of skin to synthesise vitamin D3 Lancet 1982 1 74 6 6119494
Cited by
Sorted by citations
Nutritional Management of Chronic Kidney Disease
Kalantar-Zadeh, K., & Fouque, D. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1700312 · Cited by 636 · see citing works
Taking race out of human genetics
Yudell, M., Roberts, D., DeSalle, R., & Tishkoff, S. (2016) · Science · doi:10.1126/science.aac4951 · Cited by 631 · see citing works
Vitamin D hormone regulates serotonin synthesis. Part 1: Relevance for autism
Patrick, R. P., & Ames, B. N. (2014) · The FASEB Journal · doi:10.1096/fj.13-246546 · Cited by 414 · see citing works
Vitamin D and the athlete: current perspectives and new challenges
Owens, D. J., Allison, R., & Close, G. L. (2018) · Sports Medicine · doi:10.1007/s40279-017-0841-9 · Cited by 223 · see citing works
Mousavi, S. E., Amini, H., Heydarpour, P., Amini Chermahini, F., & Godderis, L. (2019) · Environment International · doi:10.1016/j.envint.2018.11.052 · Cited by 202 · see citing works
Lucas, R. M., Norval, M., Neale, R. E., Young, A. R., de Gruijl, F. R., Takizawa, Y., & van der Leun, J. C. (2014) · Photochemical & Photobiological Sciences · doi:10.1039/c4pp90033b · Cited by 158 · see citing works
Mechanisms in endocrinology: vitamin D as a potential contributor in endocrine health and disease
Muscogiuri, G., Mitri, J., Mathieu, C., Badenhoop, K., Tamer, G., Orio, F., Mezza, T., Vieth, R., Colao, A., & Pittas, A. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0158 · Cited by 157 · see citing works
Mechanisms of vitamin D action in skeletal muscle
Montenegro, K. R., Cruzat, V., Carlessi, R., & Newsholme, P. (2019) · Nutrition Research Reviews · doi:10.1017/s0954422419000064 · Cited by 147 · see citing works
Vitamin D–Binding Protein Concentrations Quantified by Mass Spectrometry
Hoofnagle, A. N., Eckfeldt, J. H., & Lutsey, P. L. (2015) · New England Journal of Medicine · doi:10.1056/nejmc1502602 · Cited by 103 · see citing works
Narinx, N., David, K., Walravens, J., Vermeersch, P., Claessens, F., Fiers, T., Lapauw, B., Antonio, L., & Vanderschueren, D. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04562-1 · Cited by 96 · see citing works
Immunomodulators in SLE: Clinical evidence and immunologic actions
Durcan, L., & Petri, M. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.06.010 · Cited by 92 · see citing works
Chen, X., Wan, Z., Geng, T., Zhu, K., Li, R., Lu, Q., Lin, X., Liu, S., Chen, L., Guo, Y., et al. (2023) · Diabetes Care · doi:10.2337/dc22-0513 · Cited by 84 · see citing works
Shih, B. B., Farrar, M. D., Cooke, M. S., Osman, J., Langton, A. K., Kift, R., Webb, A. R., Berry, J. L., Watson, R. E. B., Vail, A., et al. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.04.015 · Cited by 64 · see citing works
Xiao, J.-P., Zang, J., Pei, J.-J., Xu, F., Zhu, Y., & Liao, X.-P. (2015) · PLOS ONE · doi:10.1371/journal.pone.0117748 · Cited by 53 · see citing works
Zhang, Y., Gu, Z., Xu, Y., He, M., Gerber, B. S., Wang, Z., Liu, F., & Peng, C. (2024) · Heliyon · doi:10.1016/j.heliyon.2023.e23405 · Cited by 26 · see citing works
- Authors
- Powe, C. E., Evans, M. K., Wenger, J., Zonderman, A. B., Berg, A. H., Nalls, M., Tamez, H., Zhang, D., Bhan, I., Karumanchi, S. A., Powe, N. R., & Thadhani, R.
- Affiliations
- Brigham and Women's Hospital (US)
- National Institutes of Health (US)
- Massachusetts General Hospital (US)
- Beth Israel Deaconess Medical Center (US)
- San Francisco General Hospital (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-11-21
- Volume
- 369
- Issue
- 21
- Pages
- 1991-2000
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC4030388
- OpenAlex
- W2161519087
- Cited by
- 1,087
- References
- 3
- Citations by year
- 2026: 29 · 2025: 41 · 2024: 39 · 2023: 68 · 2022: 55 · 2021: 88 · 2020: 72 · 2019: 91 · 2018: 103 · 2017: 103 · 2016: 125 · 2015: 138 · 2014: 127 · 2013: 6 · 2012: 1
- FWCI
- 98.93
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (Z01-AG000513)
- National Institute on Aging (ZIAAG000513)
- National Institute of Diabetes and Digestive and Kidney Diseases (K24DK094872, R01DK094486)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Vitamin D Research Studies
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Keywords
- vitamin D binding protein, vitamin D status, 25-hydroxyvitamin D, vitamin D deficiency, racial differences, African Americans, White Americans, parathyroid hormone, bone mineral density, rs7041, rs4588, bioavailable vitamin D
- MeSH terms
- Biological Availability, Black or African American, Cross-Sectional Studies, Female, Genotype, Health Surveys, Homozygote, Humans, Male, Middle Aged, Parathyroid Hormone, Polymorphism, Genetic, United States, Vitamin D, Vitamin D-Binding Protein, Bone Density, White People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review